Effect of sacubitril/valsartan on investigator‐reported ventricular arrhythmias in PARADIGM‐HF

AIMS: Sudden death is a leading cause of mortality in heart failure with reduced ejection fraction (HFrEF). In PARADIGM‐HF, sacubitril/valsartan reduced the incidence of sudden death. The purpose of this post hoc study was to analyse the effect of sacubitril/valsartan, compared to enalapril, on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Curtain, James P., Jackson, Alice M., Shen, Li, Jhund, Pardeep S., Docherty, Kieran F., Petrie, Mark C., Castagno, Davide, Desai, Akshay S., Rohde, Luis E., Lefkowitz, Martin P., Rouleau, Jean‐Lucien, Zile, Michael R., Solomon, Scott D., Swedberg, Karl, Packer, Milton, McMurray, John J.V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2022
Materias:
Medical Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542658/
https://www.ncbi.nlm.nih.gov/pubmed/34969175
http://dx.doi.org/10.1002/ejhf.2419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542658/
https://www.ncbi.nlm.nih.gov/pubmed/34969175
http://dx.doi.org/10.1002/ejhf.2419

Ejemplares similares